Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Article in The Lancet (March 2024)
The most recent citing publications are shown below. View all 107 publications that cite this research output on Dimensions.
Article in The Lancet (March 2024)
Article in Journal of the Korean Ophthalmological Society (February 2024)
Article in Journal of the Korean Ophthalmological Society (September 2023)